Wiehle Ronald 4
4 · REPROS THERAPEUTICS INC. · Filed Jul 9, 2010
Insider Transaction Report
Form 4
Wiehle Ronald
Vice President, R&D
Transactions
- Award
Stock Option
2010-07-02+20,220→ 20,220 totalExercise: $0.34Exp: 2020-07-02→ Common Stock (20,220 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable at a rate of 1/4th per quarter for a period of 1 year.